CTKB Cytek Corp Gross Margin

Official company branding of Cytek Bio (CTKB)

Reliable medical logistics for the high-precision systems of Cytek Biosciences, Inc. (CTKB) ensure the stable integration of equipment into laboratories. Monthly gross margin demonstrates operational efficiency, where the 54.80 mark characterizes this parameter. Business resilience is supported by cytometry sales to clinics and institutes across various continents, while the expansion of spectral platforms aims to increase ancillary service revenues.

CTKB (cytekbio.com) Gross Margin history from 07/04/2022 to 11/19/2026

Analytical breakdowns and data insights for company Cytek Biosciences Inc (CTKB)

- stock value and consensus price forecast:
Basic company analysis:CTKB - Cytek Biosciences
Mass-produced product of Cytek Biosciences

For Cytek Biosciences, Inc. (CTKB), which holds exclusive patents for laser spectrometers, gross margin serves as an indicator of how effectively the company monetizes its technological superiority over competitors. The current gross margin value of 54.80 reflects the profit share after deducting direct production costs, allowing investors to assess the company's ability to maintain high profitability under strict FDA regulation.